Patient engagement strategies: the pharmaphorum podcastThis episode of the pharmaphorum podcast is the first in an occasional series focused on patient engagement that’s Share XPatient engagement strategies: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/patient-engagement-strategies
BMS’ Catherine Owen on pharma commercialisation: the pharmaphorum podcastEpisode 42 of the pharmaphorum podcast heard from Catherine Owen, who’s senior vice president of major markets at Share XBMS’ Catherine Owen on pharma commercialisation: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/bms-catherine-owen-pharma-commercialisation/
Virtual engagement and collaborations: the pharmaphorum podcastAs the world passes the year and a half mark of the COVID-19 pandemic, the evolving ‘new normal’ Share XVirtual engagement and collaborations: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/virtual-engagement-impetus-digital
Vertex’s Nicola Massey: the pharmaphorum podcastIn the latest episode of the podcast Dominic Tyer speaks with Nicola Massey, who’s Vertex’s senior country manager Share XVertex’s Nicola Massey: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/vertex-senior-country-manager-nicola-massey/
Organicell on regenerative medicine: the pharmaphorum podcastIn the latest episode of the podcast Dominic Tyer speaks with Dr Maria Ines ‘Mari’ Mitrani, chief science officer Share XOrganicell on regenerative medicine: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/organicell-regenerative-medicine-covid
Pharmacy and clinical research: the pharmaphorum podcastIn the latest episode of the pharmaphorum podcast, pharmaphorum’s web editor Catherine Longworth speaks to Gerald Finken, the founder Share XPharmacy and clinical research: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/pharmacy-clinical-research-rxe2/
Pharma’s post-COVID prospects: the pharmaphorum podcastIn this latest podcast, pharmaphorum spoke to Andrew Meade, life sciences lead UK and Ireland at Accenture, about Share XPharma’s post-COVID prospects: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/pharma-post-covid-prospects-accenture/
Galapagos UK’s Michael Smyth on RNA-based tech: the pharmaphorum podcastEpisode 35 of the pharmaphorum podcast hears from Michael Smyth about Galapagos UK and joining the company as Share XGalapagos UK’s Michael Smyth on RNA-based tech: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/galapago-uk-michael-smyth-rna/
Big data and cell therapy development: the pharmaphorum podcastIn the latest episode of the podcast pharmaphorum’s website editor Catherine Longworth speaks with Dr Darrin Disley, who’s the Share XBig data and cell therapy development: the pharmaphorum podcasthttps://pharmaphorum.com/podcast/mogrify-big-data-cell-therapy
